H.R. 5256: To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 10, 2025 | Introduced in House |
| Sep. 10, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.